Harrow Health (HROW) Tops Q2 EPS by 3c

Harrow Health (NASDAQ: HROW) reported Q2 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.07 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Nebius soars on second quarter revenue beat
• Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
• Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c